• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and United States Transdermal Skin Patch Market Insights, Forecast to 2026

report cover
  • 4 September 2020
  • Pharmaceuticals
  • 142 Pages
  • Report Code: 24LS-21566
  • Formate :   
Download FREE Report Sample Download PDF File

United States Transdermal Skin Patch -MARKET ADVISORY SERVICES

Transdermal Skin Patch market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Skin Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Transdermal Skin Patch market is segmented into
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch

Segment by Application, the Transdermal Skin Patch market is segmented into
Relieve Severe Pain
Stop Smoking Cigarettes
Treat An Overactive Bladder
Others

Regional and Country-level Analysis
The Transdermal Skin Patch market is analysed and market size information is provided by regions (countries).
The key regions covered in the Transdermal Skin Patch market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Transdermal Skin Patch Market Share Analysis
Transdermal Skin Patch market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transdermal Skin Patch business, the date to enter into the Transdermal Skin Patch market, Transdermal Skin Patch product introduction, recent developments, etc.
The major vendors covered:
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
1 Study Coverage
1.1 Transdermal Skin Patch Product Introduction
1.2 Market Segments
1.3 Key Transdermal Skin Patch Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Transdermal Skin Patch Market Size Growth Rate by Type
1.4.2 Fentanyl Transdermal Skin Patch
1.4.3 Nicotine Transdermal Skin Patch
1.4.4 Clonidine Transdermal Skin Patch
1.4.5 Buprenorphine Transdermal Skin Patch
1.5 Market by Application
1.5.1 Global Transdermal Skin Patch Market Size Growth Rate by Application
1.5.2 Relieve Severe Pain
1.5.3 Stop Smoking Cigarettes
1.5.4 Treat An Overactive Bladder
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Transdermal Skin Patch Market Size, Estimates and Forecasts
2.1.1 Global Transdermal Skin Patch Revenue 2015-2026
2.1.2 Global Transdermal Skin Patch Sales 2015-2026
2.2 Global Transdermal Skin Patch, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Transdermal Skin Patch Historical Market Size by Region (2015-2020)
2.3.1 Global Transdermal Skin Patch Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Transdermal Skin Patch Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Transdermal Skin Patch Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Transdermal Skin Patch Sales Forecast by Region (2021-2026)
2.4.2 Global Transdermal Skin Patch Revenue Forecast by Region (2021-2026)

3 Global Transdermal Skin Patch Competitor Landscape by Players
3.1 Global Top Transdermal Skin Patch Sales by Manufacturers
3.1.1 Global Transdermal Skin Patch Sales by Manufacturers (2015-2020)
3.1.2 Global Transdermal Skin Patch Sales Market Share by Manufacturers (2015-2020)
3.2 Global Transdermal Skin Patch Manufacturers by Revenue
3.2.1 Global Transdermal Skin Patch Revenue by Manufacturers (2015-2020)
3.2.2 Global Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transdermal Skin Patch Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Transdermal Skin Patch Revenue in 2019
3.2.5 Global Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Transdermal Skin Patch Price by Manufacturers
3.4 Global Transdermal Skin Patch Manufacturing Base Distribution, Product Types
3.4.1 Transdermal Skin Patch Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transdermal Skin Patch Product Type
3.4.3 Date of International Manufacturers Enter into Transdermal Skin Patch Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Transdermal Skin Patch Market Size by Type (2015-2020)
4.1.1 Global Transdermal Skin Patch Sales by Type (2015-2020)
4.1.2 Global Transdermal Skin Patch Revenue by Type (2015-2020)
4.1.3 Transdermal Skin Patch Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Transdermal Skin Patch Market Size Forecast by Type (2021-2026)
4.2.1 Global Transdermal Skin Patch Sales Forecast by Type (2021-2026)
4.2.2 Global Transdermal Skin Patch Revenue Forecast by Type (2021-2026)
4.2.3 Transdermal Skin Patch Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Transdermal Skin Patch Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Transdermal Skin Patch Market Size by Application (2015-2020)
5.1.1 Global Transdermal Skin Patch Sales by Application (2015-2020)
5.1.2 Global Transdermal Skin Patch Revenue by Application (2015-2020)
5.1.3 Transdermal Skin Patch Price by Application (2015-2020)
5.2 Transdermal Skin Patch Market Size Forecast by Application (2021-2026)
5.2.1 Global Transdermal Skin Patch Sales Forecast by Application (2021-2026)
5.2.2 Global Transdermal Skin Patch Revenue Forecast by Application (2021-2026)
5.2.3 Global Transdermal Skin Patch Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Transdermal Skin Patch Market Size YoY Growth 2015-2026
6.1.1 United States Transdermal Skin Patch Sales YoY Growth 2015-2026
6.1.2 United States Transdermal Skin Patch Revenue YoY Growth 2015-2026
6.1.3 United States Transdermal Skin Patch Market Share in Global Market 2015-2026
6.2 United States Transdermal Skin Patch Market Size by Players (International and Local Players)
6.2.1 United States Top Transdermal Skin Patch Players by Sales (2015-2020)
6.2.2 United States Top Transdermal Skin Patch Players by Revenue (2015-2020)
6.3 United States Transdermal Skin Patch Historic Market Review by Type (2015-2020)
6.3.1 United States Transdermal Skin Patch Sales Market Share by Type (2015-2020)
6.3.2 United States Transdermal Skin Patch Revenue Market Share by Type (2015-2020)
6.3.3 United States Transdermal Skin Patch Price by Type (2015-2020)
6.4 United States Transdermal Skin Patch Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Transdermal Skin Patch Sales Forecast by Type (2021-2026)
6.4.2 United States Transdermal Skin Patch Revenue Forecast by Type (2021-2026)
6.4.3 United States Transdermal Skin Patch Price Forecast by Type (2021-2026)
6.5 United States Transdermal Skin Patch Historic Market Review by Application (2015-2020)
6.5.1 United States Transdermal Skin Patch Sales Market Share by Application (2015-2020)
6.5.2 United States Transdermal Skin Patch Revenue Market Share by Application (2015-2020)
6.5.3 United States Transdermal Skin Patch Price by Application (2015-2020)
6.6 United States Transdermal Skin Patch Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Transdermal Skin Patch Sales Forecast by Application (2021-2026)
6.6.2 United States Transdermal Skin Patch Revenue Forecast by Application (2021-2026)
6.6.3 United States Transdermal Skin Patch Price Forecast by Application (2021-2026)

7 North America
7.1 North America Transdermal Skin Patch Market Size YoY Growth 2015-2026
7.2 North America Transdermal Skin Patch Market Facts & Figures by Country
7.2.1 North America Transdermal Skin Patch Sales by Country (2015-2020)
7.2.2 North America Transdermal Skin Patch Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Transdermal Skin Patch Market Size YoY Growth 2015-2026
8.2 Europe Transdermal Skin Patch Market Facts & Figures by Country
8.2.1 Europe Transdermal Skin Patch Sales by Country
8.2.2 Europe Transdermal Skin Patch Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Transdermal Skin Patch Market Size YoY Growth 2015-2026
9.2 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Country
9.2.1 Asia Pacific Transdermal Skin Patch Sales by Region (2015-2020)
9.2.2 Asia Pacific Transdermal Skin Patch Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Transdermal Skin Patch Market Size YoY Growth 2015-2026
10.2 Latin America Transdermal Skin Patch Market Facts & Figures by Country
10.2.1 Latin America Transdermal Skin Patch Sales by Country
10.2.2 Latin America Transdermal Skin Patch Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Transdermal Skin Patch Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Country
11.2.1 Middle East and Africa Transdermal Skin Patch Sales by Country
11.2.2 Middle East and Africa Transdermal Skin Patch Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Hisamitsu Pharmaceutical
12.1.1 Hisamitsu Pharmaceutical Corporation Information
12.1.2 Hisamitsu Pharmaceutical Description and Business Overview
12.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
12.1.5 Hisamitsu Pharmaceutical Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Transdermal Skin Patch Products Offered
12.2.5 Novartis Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson Transdermal Skin Patch Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Teikoku Pharma
12.4.1 Teikoku Pharma Corporation Information
12.4.2 Teikoku Pharma Description and Business Overview
12.4.3 Teikoku Pharma Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Teikoku Pharma Transdermal Skin Patch Products Offered
12.4.5 Teikoku Pharma Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Description and Business Overview
12.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Transdermal Skin Patch Products Offered
12.5.5 Mylan Recent Development
12.6 Actavis
12.6.1 Actavis Corporation Information
12.6.2 Actavis Description and Business Overview
12.6.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Actavis Transdermal Skin Patch Products Offered
12.6.5 Actavis Recent Development
12.7 Mundipharma
12.7.1 Mundipharma Corporation Information
12.7.2 Mundipharma Description and Business Overview
12.7.3 Mundipharma Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Mundipharma Transdermal Skin Patch Products Offered
12.7.5 Mundipharma Recent Development
12.8 Henan Lingrui Pharmaceutical
12.8.1 Henan Lingrui Pharmaceutical Corporation Information
12.8.2 Henan Lingrui Pharmaceutical Description and Business Overview
12.8.3 Henan Lingrui Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Products Offered
12.8.5 Henan Lingrui Pharmaceutical Recent Development
12.9 Changzhou Siyao
12.9.1 Changzhou Siyao Corporation Information
12.9.2 Changzhou Siyao Description and Business Overview
12.9.3 Changzhou Siyao Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Changzhou Siyao Transdermal Skin Patch Products Offered
12.9.5 Changzhou Siyao Recent Development
12.10 Rfl Pharmaceutical
12.10.1 Rfl Pharmaceutical Corporation Information
12.10.2 Rfl Pharmaceutical Description and Business Overview
12.10.3 Rfl Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Rfl Pharmaceutical Transdermal Skin Patch Products Offered
12.10.5 Rfl Pharmaceutical Recent Development
12.11 Hisamitsu Pharmaceutical
12.11.1 Hisamitsu Pharmaceutical Corporation Information
12.11.2 Hisamitsu Pharmaceutical Description and Business Overview
12.11.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
12.11.5 Hisamitsu Pharmaceutical Recent Development
12.12 Purdue Pharma L.P.
12.12.1 Purdue Pharma L.P. Corporation Information
12.12.2 Purdue Pharma L.P. Description and Business Overview
12.12.3 Purdue Pharma L.P. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Purdue Pharma L.P. Products Offered
12.12.5 Purdue Pharma L.P. Recent Development
12.13 Teva Pharmaceutical Industries Ltd.
12.13.1 Teva Pharmaceutical Industries Ltd. Corporation Information
12.13.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
12.13.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Teva Pharmaceutical Industries Ltd. Products Offered
12.13.5 Teva Pharmaceutical Industries Ltd. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Transdermal Skin Patch Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transdermal Skin Patch Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Transdermal Skin Patch Market Segments

Table 2. Ranking of Global Top Transdermal Skin Patch Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Transdermal Skin Patch Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

Table 4. Major Manufacturers of Fentanyl Transdermal Skin Patch

Table 5. Major Manufacturers of Nicotine Transdermal Skin Patch

Table 6. Major Manufacturers of Clonidine Transdermal Skin Patch

Table 7. Major Manufacturers of Buprenorphine Transdermal Skin Patch

Table 8. Global Transdermal Skin Patch Market Size Growth Rate by Application 2020-2026 (K Units)

Table 9. Global Transdermal Skin Patch Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

Table 10. Global Transdermal Skin Patch Sales by Regions 2015-2020 (K Units)

Table 11. Global Transdermal Skin Patch Sales Market Share by Regions (2015-2020)

Table 12. Global Transdermal Skin Patch Revenue by Regions 2015-2020 (US$ Million)

Table 13. Global Transdermal Skin Patch Sales Forecast by Region (2021-2026) (K Units)

Table 14. Global Transdermal Skin Patch Sales by Manufacturers (2015-2020) (K Units)

Table 15. Global Transdermal Skin Patch Sales Share by Manufacturers (2015-2020)

Table 16. Global Transdermal Skin Patch Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 17. Global Transdermal Skin Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Skin Patch as of 2019)

Table 18. Transdermal Skin Patch Revenue by Manufacturers (2015-2020) (US$ Million)

Table 19. Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)

Table 20. Key Manufacturers Transdermal Skin Patch Price (2015-2020) (USD/Unit)

Table 21. Transdermal Skin Patch Manufacturers Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Transdermal Skin Patch Product Type

Table 23. Date of International Manufacturers Enter into Transdermal Skin Patch Market

Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 25. Global Transdermal Skin Patch Sales by Type (2015-2020) (K Units)

Table 26. Global Transdermal Skin Patch Sales Share by Type (2015-2020)

Table 27. Global Transdermal Skin Patch Revenue by Type (2015-2020) (US$ Million)

Table 28. Global Transdermal Skin Patch Revenue Share by Type (2015-2020)

Table 29. Transdermal Skin Patch Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)

Table 30. Global Transdermal Skin Patch Sales Share by Type (2021-2026)

Table 31. Global Transdermal Skin Patch Sales by Application (2015-2020) (K Units)

Table 32. Global Transdermal Skin Patch Sales Share by Application (2015-2020)

Table 33. Global Transdermal Skin Patch Sales Share by Application (2021-2026)

Table 34. Global Transdermal Skin Patch Sales Market Share Forecast by Application (2021-2026)

Table 35. Global Transdermal Skin Patch Revenue by Application (2015-2020) (US$ Million)

Table 36. Global Transdermal Skin Patch Revenue Market Share Forecast by Application (2021-2026)

Table 37. United States Transdermal Skin Patch Sales (K Units) of Key Companies (2015-2020)

Table 38. United States Transdermal Skin Patch Sales Share by Company (2015-2020)

Table 39. United States Transdermal Skin Patch Revenue (US$ Million) by Company (2015-2020)

Table 40. United States Transdermal Skin Patch Sales (K Units) by Type (2015-2020)

Table 41. United States Transdermal Skin Patch Sales Share by Type (2015-2020)

Table 42. United States Transdermal Skin Patch Revenue (US$ Million) Market Share by Type (2015-2020)

Table 43. United States Transdermal Skin Patch Price (K Units) by Type (2015-2020)

Table 44. United States Transdermal Skin Patch Sales (K Units) by Type (2021-2026)

Table 45. United States Transdermal Skin Patch Sales Share by Type (2021-2026)

Table 46. United States Transdermal Skin Patch Revenue (US$ Million) Market Share by Type (2021-2026)

Table 47. United States Transdermal Skin Patch Revenue Share by Type (2021-2026)

Table 48. United States Transdermal Skin Patch Price (K Units) by Type (2021-2026)

Table 49. United States Transdermal Skin Patch Sales (K Units) by Application (2015-2020)

Table 50. United States Transdermal Skin Patch Sales Share by Application (2015-2020)

Table 51. United States Transdermal Skin Patch Revenue (US$ Million) Market Share by Application (2015-2020)

Table 52. United States Transdermal Skin Patch Sales (K Units) by Application (2021-2026)

Table 53. United States Transdermal Skin Patch Sales Share by Application (2021-2026)

Table 54. United States Transdermal Skin Patch Revenue (US$ Million) Market Share by Application (2021-2026)

Table 55. United States Transdermal Skin Patch Revenue Share by Application (2021-2026)

Table 56. North America Transdermal Skin Patch Sales by Country (2015-2020) (K Units)

Table 57. North America Transdermal Skin Patch Sales Market Share by Country (2015-2020)

Table 58. North America Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)

Table 59. North America Transdermal Skin Patch Revenue Market Share by Country (2015-2020)

Table 60. Europe Transdermal Skin Patch Sales by Country (2015-2020) (K Units)

Table 61. Europe Transdermal Skin Patch Sales Market Share by Country (2015-2020)

Table 62. Europe Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)

Table 63. Europe Transdermal Skin Patch Revenue Market Share by Country (2015-2020)

Table 64. Asia Pacific Transdermal Skin Patch Sales by Region (2015-2020) (K Units)

Table 65. Asia Pacific Transdermal Skin Patch Sales Market Share by Region (2015-2020)

Table 66. Asia Pacific Transdermal Skin Patch Revenue by Region (2015-2020) (US$ Million)

Table 67. Asia Pacific Transdermal Skin Patch Revenue Market Share by Region (2015-2020)

Table 68. Latin America Transdermal Skin Patch Sales by Country (2015-2020) (K Units)

Table 69. Latin America Transdermal Skin Patch Sales Market Share by Country (2015-2020)

Table 70. Latin Americaa Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)

Table 71. Latin America Transdermal Skin Patch Revenue Market Share by Country (2015-2020)

Table 72. Middle East and Africa Transdermal Skin Patch Sales by Country (2015-2020) (K Units)

Table 73. Middle East and Africa Transdermal Skin Patch Sales Market Share by Country (2015-2020)

Table 74. Middle East and Africa Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)

Table 75. Middle East and Africa Transdermal Skin Patch Revenue Market Share by Country (2015-2020)

Table 76. Hisamitsu Pharmaceutical Corporation Information

Table 77. Hisamitsu Pharmaceutical Description and Business Overview

Table 78. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 79. Hisamitsu Pharmaceutical Transdermal Skin Patch Product

Table 80. Hisamitsu Pharmaceutical Recent Development

Table 81. Novartis Corporation Information

Table 82. Novartis Description and Business Overview

Table 83. Novartis Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 84. Novartis Product

Table 85. Novartis Recent Development

Table 86. Johnson & Johnson Corporation Information

Table 87. Johnson & Johnson Description and Business Overview

Table 88. Johnson & Johnson Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 89. Johnson & Johnson Product

Table 90. Johnson & Johnson Recent Development

Table 91. Teikoku Pharma Corporation Information

Table 92. Teikoku Pharma Description and Business Overview

Table 93. Teikoku Pharma Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 94. Teikoku Pharma Product

Table 95. Teikoku Pharma Recent Development

Table 96. Mylan Corporation Information

Table 97. Mylan Description and Business Overview

Table 98. Mylan Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 99. Mylan Product

Table 100. Mylan Recent Development

Table 101. Actavis Corporation Information

Table 102. Actavis Description and Business Overview

Table 103. Actavis Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 104. Actavis Product

Table 105. Actavis Recent Development

Table 106. Mundipharma Corporation Information

Table 107. Mundipharma Description and Business Overview

Table 108. Mundipharma Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 109. Mundipharma Product

Table 110. Mundipharma Recent Development

Table 111. Henan Lingrui Pharmaceutical Corporation Information

Table 112. Henan Lingrui Pharmaceutical Description and Business Overview

Table 113. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 114. Henan Lingrui Pharmaceutical Product

Table 115. Henan Lingrui Pharmaceutical Recent Development

Table 116. Changzhou Siyao Corporation Information

Table 117. Changzhou Siyao Description and Business Overview

Table 118. Changzhou Siyao Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 119. Changzhou Siyao Product

Table 120. Changzhou Siyao Recent Development

Table 121. Rfl Pharmaceutical Corporation Information

Table 122. Rfl Pharmaceutical Description and Business Overview

Table 123. Rfl Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 124. Rfl Pharmaceutical Product

Table 125. Rfl Pharmaceutical Recent Development

Table 126. Luye Pharma Group Ltd. Corporation Information

Table 127. Luye Pharma Group Ltd. Description and Business Overview

Table 128. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 129. Luye Pharma Group Ltd. Product

Table 130. Luye Pharma Group Ltd. Recent Development

Table 131. Purdue Pharma L.P. Corporation Information

Table 132. Purdue Pharma L.P. Description and Business Overview

Table 133. Purdue Pharma L.P. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 134. Purdue Pharma L.P. Product

Table 135. Purdue Pharma L.P. Recent Development

Table 136. Teva Pharmaceutical Industries Ltd. Corporation Information

Table 137. Teva Pharmaceutical Industries Ltd. Description and Business Overview

Table 138. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 139. Teva Pharmaceutical Industries Ltd. Product

Table 140. Teva Pharmaceutical Industries Ltd. Recent Development

Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 142. Key Challenges

Table 143. Market Risks

Table 144. Main Points Interviewed from Key Transdermal Skin Patch Players

Table 145. Transdermal Skin Patch Customers List

Table 146. Transdermal Skin Patch Distributors List

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Transdermal Skin Patch Product Picture

Figure 2. Global Transdermal Skin Patch Sales Market Share by Type in 2020 & 2026

Figure 3. Fentanyl Transdermal Skin Patch Product Picture

Figure 4. Nicotine Transdermal Skin Patch Product Picture

Figure 5. Clonidine Transdermal Skin Patch Product Picture

Figure 6. Buprenorphine Transdermal Skin Patch Product Picture

Figure 7. Global Transdermal Skin Patch Sales Market Share by Application in 2020 & 2026

Figure 8. Relieve Severe Pain

Figure 9. Stop Smoking Cigarettes

Figure 10. Treat An Overactive Bladder

Figure 11. Others

Figure 12. Transdermal Skin Patch Report Years Considered

Figure 13. Global Transdermal Skin Patch Market Size 2015-2026 (US$ Million)

Figure 14. Global Transdermal Skin Patch Sales 2015-2026 (K Units)

Figure 15. Global Transdermal Skin Patch Market Size Market Share by Region: 2020 Versus 2026

Figure 16. Global Transdermal Skin Patch Sales Market Share by Region (2015-2020)

Figure 17. Global Transdermal Skin Patch Sales Market Share by Region in 2019

Figure 18. Global Transdermal Skin Patch Revenue Market Share by Region (2015-2020)

Figure 19. Global Transdermal Skin Patch Revenue Market Share by Region in 2019

Figure 20. Global Transdermal Skin Patch Sales Share by Manufacturer in 2019

Figure 21. The Top 10 and 5 Players Market Share by Transdermal Skin Patch Revenue in 2019

Figure 22. Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 23. Global Transdermal Skin Patch Sales Market Share by Type (2015-2020)

Figure 24. Global Transdermal Skin Patch Sales Market Share by Type in 2019

Figure 25. Global Transdermal Skin Patch Revenue Market Share by Type (2015-2020)

Figure 26. Global Transdermal Skin Patch Revenue Market Share by Type in 2019

Figure 27. Global Transdermal Skin Patch Market Share by Price Range (2015-2020)

Figure 28. Global Transdermal Skin Patch Sales Market Share by Application (2015-2020)

Figure 29. Global Transdermal Skin Patch Sales Market Share by Application in 2019

Figure 30. Global Transdermal Skin Patch Revenue Market Share by Application (2015-2020)

Figure 31. Global Transdermal Skin Patch Revenue Market Share by Application in 2019

Figure 32. United States Transdermal Skin Patch Sales Growth Rate 2015-2026 (K Units)

Figure 33. United States Transdermal Skin Patch Revenue Growth Rate 2015-2026 (US$ Million)

Figure 34. United States Transdermal Skin Patch Market Share in Global Market 2015-2026

Figure 35. United States 5 and 10 Largest Transdermal Skin Patch Players Market Share by Revenue in Transdermal Skin Patch in 2019

Figure 36. United States Transdermal Skin Patch Revenue Share by Type (2015-2020)

Figure 37. United States Transdermal Skin Patch Revenue Growth Rate by Type in 2015 & 2019

Figure 38. United States Transdermal Skin Patch Revenue Share by Application (2015-2020)

Figure 39. United States Transdermal Skin Patch Revenue Growth Rate by Application in 2015 & 2019

Figure 40. North America Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)

Figure 41. North America Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)

Figure 42. North America Transdermal Skin Patch Sales Market Share by Country in 2019

Figure 43. North America Transdermal Skin Patch Revenue Market Share by Country in 2019

Figure 44. U.S. Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 45. U.S. Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. Canada Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 47. Canada Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 48. Europe Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)

Figure 49. Europe Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)

Figure 50. Europe Transdermal Skin Patch Sales Market Share by Country in 2019

Figure 51. Europe Transdermal Skin Patch Revenue Market Share by Country in 2019

Figure 52. Germany Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 53. Germany Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. France Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 55. France Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. U.K. Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 57. U.K. Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Italy Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 59. Italy Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Russia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 61. Russia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 62. Asia Pacific Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)

Figure 63. Asia Pacific Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)

Figure 64. Asia Pacific Transdermal Skin Patch Sales Market Share by Region in 2019

Figure 65. Asia Pacific Transdermal Skin Patch Revenue Market Share by Region in 2019

Figure 66. China Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 67. China Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. Japan Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 69. Japan Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. South Korea Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 71. South Korea Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. India Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 73. India Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Australia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 75. Australia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Taiwan Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 77. Taiwan Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Indonesia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 79. Indonesia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Thailand Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 81. Thailand Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Malaysia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 83. Malaysia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 84. Philippines Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 85. Philippines Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 86. Vietnam Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 87. Vietnam Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 88. Latin America Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)

Figure 89. Latin America Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)

Figure 90. Latin America Transdermal Skin Patch Sales Market Share by Country in 2019

Figure 91. Latin America Transdermal Skin Patch Revenue Market Share by Country in 2019

Figure 92. Mexico Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 93. Mexico Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 94. Brazil Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 95. Brazil Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 96. Argentina Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 97. Argentina Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 98. Middle East and Africa Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)

Figure 99. Middle East and Africa Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)

Figure 100. Middle East and Africa Transdermal Skin Patch Sales Market Share by Country in 2019

Figure 101. Middle East and Africa Transdermal Skin Patch Revenue Market Share by Country in 2019

Figure 102. Turkey Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 103. Turkey Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 104. Saudi Arabia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 105. Saudi Arabia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. U.A.E Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)

Figure 107. U.A.E Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)

Figure 108. Porter's Five Forces Analysis

Figure 109. Transdermal Skin Patch Value Chain

Figure 110. Channels of Distribution

Figure 111. Distributors Profiles

Figure 112. Bottom-up and Top-down Approaches for This Report

Figure 113. Data Triangulation

Figure 114. Key Executives Interviewed

Hisamitsu Pharmaceutical

Novartis

Johnson & Johnson

Teikoku Pharma

Mylan

Actavis

Mundipharma

Henan Lingrui Pharmaceutical

Changzhou Siyao

Rfl Pharmaceutical

Luye Pharma Group Ltd.

Purdue Pharma L.P.

Teva Pharmaceutical Industries Ltd.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3081

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase